Clinical trials recruiting for Anemia of Chronic Kidney Disease
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Darbepoetin Alfa | 1 |
| Desidustat | 1 |
| Efepoetin Alfa | 1 |
| Enarodustat | 1 |
Self-screener
Recruiting trials
- A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
- A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study)
- Real-World Study of Enarodustat for Anemia in Non-Dialysis CKD Patients
Related conditions
Trials recruiting for Anemia of Chronic Kidney Disease often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Anemia of Chronic Kidney Disease trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.